EDMONTON, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”), a
growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and
cosmetic industries, announced today that Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro, will provide a corporate update to
on-site shareholders on Tuesday, May 29, 2018 at 8:30 a.m. MDT at the Westin Hotel, Edmonton, AB. Mr. Gagnon’s presentation will be
followed by the Annual General and Special Meeting of Shareholders to be held at 10:00 a.m. MDT in the Centennial Room of the
Westin Hotel. Shareholders are invited to breakfast, which will begin at 7:30 a.m. MDT.
As part of his presentation, Mr. Gagnon will provide a corporate overview and an update on the Company’s
de-risked cosmeceuticals business. Mr. Gagnon will also discuss the Company’s long-term strategic vision of leveraging its two
pharmaceutical-grade active ingredient value drivers, avenanthramides and beta glucan, and their development into different
formulations to enable the transition into the high-value nutraceutical and pharmaceutical sectors.
The presentation used during Mr. Gagnon’s prepared remarks for the corporate update will be made available on
the Company’s website (www.ceapro.com) on May 29, 2018.
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology
and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant
resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics
products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology,
biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and
drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.
For more information contact:
Jenene Thomas
Jenene Thomas Communications, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
